1|0|Public
50|$|<b>Adatanserin</b> (WY-50,324, SEB-324) {{is a mixed}} 5-HT1A {{receptor}} partial agonist and 5-HT2A and 5-HT2C receptor antagonist. It {{was under}} development by Wyeth as an antidepressant but was ultimately not pursued.|$|E

